Drug Trial Radar · NCT06388889
Phase III Long-Term Extension Study With Dexpramipexole
Last checked: Nov 19, 2026Latest source record: Dec 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
509
Actual
Start
Jun 12, 2024
Primary completion
Dec 8, 2025
Study completion Dec 8, 2025
Sponsor
- Lead sponsor
- Areteia TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Apr 29, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial\] is to evaluate the long term safety of dexpramipexole treatment in participants with severe asthma, aged ≥18 years, on Global Initiative for Asthma (GINA) 2021 \[GINA, 2021\] Step 4 or 5 therapy and who completed either of the Phase III studies EXHALE-2 or EXHALE-3.
Conditions
- Eosinophilic Asthma
Interventions
Dexpramipexole DihydrochlorideDrug
Oral administration of dexpramipexole tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number and Percentage of Participants with a Treatment Emergent Adverse EventTime frame: 52 weeks
- Number and Percentage of Participants with Potentially Clinically Significant Postbaseline Changes in Clinical Laboratory EvaluationsTime frame: 52 weeks
- Number and Percentage of Participants with Potentially Clinically Significant Postbaseline Changes in Vital Signs and Body WeightTime frame: 52 weeks
- Number and Percentage of Participants with Potentially Significant Postbaseline Changes in Electrocardiogram ParametersTime frame: 52 weeks
Locations
103 sites in 15 countries. Site status is shown where the registry gives one.
Research Site 20001-374
Bakersfield, California
Research Site 20001-376
Northridge, California
Research Site 20001-029
Coral Gables, Florida
Research Site 20001-014
Greenacres City, Florida
Research Site 30001-291
Jacksonville, Florida
Research Site 20001-066
Miami, Florida
Research Site 20001-001
Miami, Florida
Research Site 20001-311
Miami, Florida
Research Site 20001-026
Miami, Florida
Research Site 30001-082
Miami, Florida
Research Site 20001-024
Miami, Florida
Research Site 20054-024
Miami, Florida
Research Site 30001-429
Plantation, Florida
Research Site 30001-429
Plantation, Florida
Research Site 20001-004
Tampa, Florida
Research Site 20001-036
Elwood, Indiana
Research Site 20001-044
Evansville, Indiana
Research Site 20001-006
Flint, Michigan
Research Site 20001-046
St Louis, Missouri
Research Site 20001-355
Toms River, New Jersey
Research Site 20001-047
Hawthorne, New York
Research Site 20001-063
Toledo, Ohio
Research Site 30001-297
Pearland, Texas
Research Site 30054-044
Buenos Aires, Argentina
Research Site 20054-017
Buenos Aires, Argentina
Research Site 20054-015
Buenos Aires, Argentina
Research Site 20054-022
Buenos Aires, Argentina
Research Site 20054-024
Buenos Aires, Argentina
Research Site 20054-008
Buenos Aires, Argentina
Research Site 20054-005
Córdoba, Argentina
Research Site 30054-047
Mendoza, Argentina
Research Site 20054-019
Mendoza, Argentina
Research Site 20054-016
Mendoza, Argentina
Research Site 20054-010
Mendoza, Argentina
Research Site 20054-002
San Miguel de Tucumán, Argentina
Research Site 20054-020
San Miguel de Tucumán, Argentina
Research Site 20054-013
Santa Fe, Argentina
Research Site 20055-007
Blumenau, Brazil
Research Site 20055-004
Porto Alegre, Brazil
Research Site 20055-010
Porto Alegre, Brazil
Showing 40 of 103 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.